Priyanka Tiwari
Share
Suspense crime, Digital Desk : A major breakthrough in the treatment of snakebites has been achieved, thanks to an extraordinary collaboration between scientists and a snake enthusiast from Wisconsin with a unique and dangerous hobby. Researchers have successfully developed a prototype for a universal antivenom capable of neutralizing the venom of a wide range of deadly snakes from different continents.
The key to this discovery lies in the blood of Tim Friede, a man who has spent over 20 years deliberately allowing venomous snakes, including Black Mambas and King Cobras, to bite him. Through this process of self-immunization, his body has developed an incredibly powerful and diverse array of antibodies against snake venom.
Scientists from the Ichan School of Medicine at Mount Sinai in New York studied Friede's blood and isolated the potent antibodies his immune system produced. They then used these antibodies as a blueprint to create a lab-grown cocktail of "humanized" monoclonal antibodies.
In preclinical trials, this new antibody cocktail proved remarkably effective. It protected mice from the otherwise lethal venom of snakes from both Africa and Asia, including the Black Mamba and the King Cobra.
This development is a significant step towards creating a single, globally effective antivenom. Current treatments are species-specific, expensive, often have severe side effects, and require refrigeration, making them impractical for many remote, rural areas where snakebites are most common. A universal antivenom would revolutionize global public health by providing a safer, more accessible, and more effective treatment for one of the world's most neglected medical emergencies.
Read More: Three Killed as Iranian Ballistic Missile Strikes Israeli City of Be'er Sheva
--Advertisement--
